Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC BAW2881
SDP

Catalog No. 5000000473
Encompass_Preferred

BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1 0-4 3 nanomolar (nM) concentrations and inhibits PDGFR c-Kit and RET (c-RET) at 45-72 nM concentrations

Catalog No. 50-000-00473 Supplier Selleck Chemical LLC Supplier No. S81895MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1 0-4 3 nanomolar (nM) concentrations and inhibits PDGFR c-Kit and RET (c-RET) at 45-72 nM concentrations

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.